UK-US M&A: Navigating Structural Differences in Cross-Border Transactions

As cross-border M&A activity between the United Kingdom and the United States continues to evolve, structural differences between the two markets are playing an increasingly important role in M&A transaction execution and risk allocation.

Divergent approaches to deal certainty, regulatory approvals, pricing mechanisms, disclosure, liability, and insurance can significantly affect transaction timelines, negotiating leverage, and post-closing exposure. Heightened regulatory scrutiny, evolving foreign direct investment regimes, and continued valuation uncertainty are increasing the importance of thoughtful transaction structuring. Companies pursuing transatlantic M&A transactions should carefully and proactively consider these distinctions to better align legal frameworks with commercial objectives and mitigate execution risk.

KEY TAKEAWAYS

• Deal Certainty: UK M&A transactions prioritize deal certainty and seller protection through limited closing conditions and narrower termination rights. Conversely, US M&A transactions often provide buyers with broader protections, including material adverse change clauses, covenant compliance conditions, and more extensive warranty bring-down requirements. Aligning how risk is priced, transferred, and enforced is a key focus in the negotiations of cross-border M&A transactions between the United States and the United Kingdom.
• Regulatory Strategy: Regulatory risk has become a central driver of M&A transaction outcomes. The UK National Security and Investment Act 2021, expanded European Union foreign direct investment regimes, and increasingly active reviews from the Committee on Foreign Investment in the United States are extending timelines, increasing complexity, and requiring regulatory considerations to be preemptively embedded in deal strategy.
• Valuation Gaps: Market volatility and valuation uncertainty are driving greater use of alternative pricing mechanisms. Parties are increasingly adopting hybrid structures and earn-outs to bridge valuation gaps and facilitate deal execution. Notably, while earn-outs can solve pricing challenges, they may increase the risk of post-closing disputes.
• Information and Disclosure: Disclosure and liability regimes remain an important source of transatlantic negotiation friction. UK M&A transactions generally operate within a stronger buyer-beware framework, while US M&A transactions are more indemnity driven, often providing buyers with broader avenues for recovery.
• The Role of Insurance: Insurance continues to influence negotiations, but it is not a substitute for diligence. Warranty and Indemnity/Representations and Warranties insurance remains a valuable risk-transfer tool; however, parties must continue to focus on robust diligence, clear drafting, and a thorough understanding of policy limitations and exclusions.
• Emerging Risks: Diligence is expanding beyond traditional legal and financial issues. Cybersecurity, artificial intelligence, data governance, environmental, social, and governance matters, sanctions compliance, and supply chain resilience are becoming material transaction considerations.

LOOKING AHEAD

There is no “optimal” structure for a cross-border M&A transaction. Successful M&A transactions are those that identify key legal, regulatory, tax, and commercial risks early and align transaction structures with the parties’ strategic objectives and risk tolerance. As regulatory scrutiny intensifies and market participants continue to navigate valuation uncertainty, companies pursuing UK-US M&A transactions should take a proactive approach to deal structuring, regulatory planning, and diligence to enhance execution certainty and reduce post-closing risk.